P2.08. A Phase II Study of Subcutaneous (SC) Atezolizumab in NSCLC Patients Using a Decentralized Clinical Trial Model - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Jorge Nieva
Meta Tag
Speaker Jorge Nieva
Topic Metastatic NSCLC: Immunotherapy - TIPs
Phase II study
checkpoint inhibitor therapy
home administration
remote clinical trial model
subcutaneous atezolizumab
non-small cell lung cancer
decentralized trial model
cancer patients
distributed clinical trials
Powered By